DNA Therapeutics develops targeted drugs against resistant cancer with a lead IMP demonstrating good safety & antitumor activity in patients
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free